Voting Rights: An Overview
The concept of voting rights is essential for shareholders in understanding their influence within a company. It often correlates with the number of shares a shareholder possesses. Each share typically grants the investor a voice in key company decisions, such as board elections and corporate policies.
Understanding Share Capital
Share capital represents the total value of shares issued by a company. Nanobiotix, listed on Euronext Paris and the Nasdaq Global Select Market, has a defined share capital that directly impacts its financial health and shareholders' power.
The Current Landscape for Nanobiotix Shares
As of the end of October 2025, Nanobiotix has a significant number of shares outstanding, totaling approximately 48,237,471 shares. This drives their total theoretical voting rights to around 50,267,962, illustrating the extent of shareholder involvement in company decisions.
Types of Voting Rights
There are generally two types of voting rights relevant to shareholders: theoretical and exercisable. Theoretical voting rights count all shares, including those under certain restrictions. Exercisable voting rights, however, exclude shares that cannot participate in votes, ensuring clarity in shareholder engagement.
About Nanobiotix
Nanobiotix is an innovative clinical biotechnology firm aiming to transform treatment outcomes through advanced technologies. Established in 2003, the organization's vision is focused on redefining possibilities, particularly in oncology. They own over 25 patents related to their unique nanotechnology platforms.
Locations and Expansion
Headquartered in Paris, France, Nanobiotix has expanded operations internationally, including a subsidiary in Cambridge, Massachusetts. This global presence positions the company strategically within the biotechnology sector, enhancing its research and development capabilities.
Contact Information for Investors
For those interested in reaching out, Nanobiotix's communications department is led by Brandon Owens, who can be contacted at +1 (617) 852-4835. The investor relations department, spearheaded by Joanne Choi and Ricky Bhajun, also welcomes inquiries from both U.S. and EU investors.
Frequently Asked Questions
What are voting rights?
Voting rights give shareholders a say in corporate governance, typically proportional to the shares they own.
How many shares does Nanobiotix currently have?
As of late October 2025, Nanobiotix has 48,237,471 shares outstanding.
What is the significance of exercisable voting rights?
Exercisable voting rights are essential for participating in shareholder meetings and decision-making processes.
Where is Nanobiotix headquartered?
Nanobiotix is headquartered in Paris, France, with various global subsidiaries.
Who can I contact for investor relations at Nanobiotix?
Investors can contact the communications department or the investor relations department directly for inquiries.
